ArticleBMC pulmonary medicine2026
Defining obstruction in COPD: do fixed ratio and lower limit of normal criteria reflect different clinical characteristics? findings from a Greek cross-sectional study (EMENO).
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
BACKGROUND AND
objectivesIn epidemiological research, spirometry is commonly used to estimate prevalence of COPD, as reliance on imprecisely delineated symptoms may introduce bias. Actually, the prevalence of airflow limitation in adults with no prior asthma diagnosis was studied using two different cut-offs for the FEV₁/FVC ratio: the fixed ratio (FR) and the lower limit of normal (LLN), based on data from the EMENO survey. Our objective was to estimate COPD prevalence in Greece under both definitions and to compare associated clinical features and comorbidities.
methodsThe EMENO study was a population-based survey (2014–2016) of 6,006 adults (≥18 years). This analysis included 2,450 participants aged 30–91 years, with high-quality spirometry and no prior asthma diagnosis. Airflow limitation indicative of COPD was defined by pre-bronchodilator FEV1/FVC < 0.70 (FR) and FEV1/FVC < LLN; self-reported COPD (SRPD) was also analyzed. Comorbidities and demographics were assessed through interviews and medical exams.
resultsCOPD prevalence was 8.51% (FR), 5.33% (LLN), and 1.97% (SRPD). It was more common in men (13.2% FR+ and 8.5% LLN+), with the highest prevalence among current smokers (11.6%, FR; 9.1%, LLN). Prevalence was also higher in participants reporting respiratory symptoms. The FR+/LLN− (discordant) group was strongly associated with older age, blue-collar occupations, and comorbidities. Concordant cases (FR+/LLN+) had a higher prevalence of smoking and respiratory symptoms compared to discordant cases. Obesity was inversely associated with COPD under the LLN criterion, while sleep apnea syndrome increased the odds of concordant COPD.
conclusionCOPD prevalence in Greece differed according to the obstructive threshold applied, with discordant and concordant cases showing distinct demographic and clinical risk profiles. The higher prevalence of obstruction among symptomatic participants further supports the use of spirometry as a valid surrogate in epidemiological studies. Overall, reliance on a single definition may misrepresent the true burden and heterogeneity of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.